Alex, I called the company and this is what I got,
OK, projected numbers on PRFX for 1998 and 1999;
1998 sales are expected at $6.5 million, up from $3 million in
1887, with a small net profit
1999 sales are expected at $13 million, a 100% increase, with net
profit at $2.6 million, or .50 per share, (based on 5 million
shares),
2000 sales are expected at $27 million, a 100% increase, with net
profit at $7.00 million, or $1.20 per share, based on the same 5
million shares.
This company has customers with names like Aetna, Pfizer,
Proctor and Gamble, Mass Mutual, Fidelity, the US Navy, Merril
Lynch, Prudential, United Technologies, and Wellpoint, to name a
few.
It is my opinion that this stock is extremely undervalued at $4.00
per share, and is worth a lot more.
Remember, 5 million shares outstanding is nothing, and any strong
buying can bring it right to 7 or 8.
Just my opinion folks, but I think this one is a winner.
|
